Insider & Institutional Ownership
22.2% of Elevai Labs shares are held by institutional investors. 5.6% of Endonovo Therapeutics shares are held by company insiders. Comparatively, 37.0% of Elevai Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares Endonovo Therapeutics and Elevai Labs’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Endonovo Therapeutics | -6,075.54% | N/A | -279.35% |
Elevai Labs | -191.96% | -216.19% | -118.16% |
Earnings and Valuation
This table compares Endonovo Therapeutics and Elevai Labs”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Endonovo Therapeutics | $170,000.00 | 0.01 | -$400,000.00 | N/A | N/A |
Elevai Labs | $1.71 million | 0.32 | -$4.30 million | ($0.32) | -0.08 |
Summary
Elevai Labs beats Endonovo Therapeutics on 6 of the 8 factors compared between the two stocks.
About Endonovo Therapeutics
Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development of bio-electronic approach to regenerative medicine. The firm also develops, manufactures and distributes evolutionary medical devices focused on the healing of wounds and reduction of pain, edema and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, SofPulse, Electroceutical Therapy, and Scientific Studies. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.
About Elevai Labs
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.